Black Diamond Therapeutics Inc logo

BDTX - Black Diamond Therapeutics Inc News Story

$27.5 0.9  3.5%

Last Trade - 14/05/21

Sector
Healthcare
Size
Mid Cap
Market Cap £705.5m
Enterprise Value £482.0m
Revenue £n/a
Position in Universe 2850th / 6846

BRIEF-Black Diamond Therapeutics Announces Pre-Clinical Data Presentations On New Programs Targeting BRAF And FGFR At ESMO TAT Virtual Congress 2021

Tue 2nd March, 2021 9:37pm
March 2 (Reuters) - Black Diamond Therapeutics Inc  BDTX.O :
    * BLACK DIAMOND THERAPEUTICS ANNOUNCES PRE-CLINICAL DATA
PRESENTATIONS ON NEW PROGRAMS TARGETING BRAF AND FGFR AT ESMO
TAT VIRTUAL CONGRESS 2021

Source text for Eikon:  ID:nGNX4H7T1L 
Further company coverage:  BDTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.